Publications 2021

Christensen EE, Jorgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM (2021)
Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns
J. Intern. Med., 290 (3), 677-692
DOI 10.1111/joim.13310

Publications 2020

Arain F, Abraityte A, Bogdanova M, Solberg OG, Michelsen AE, Lekva T, Aakhus S, Holm S, Halvorsen B, Finsen AV, Vinge LE, Nymo S, Espeland T, Ranheim T, Aukrust P, Vaage IJ, Auensen A, Gullestad L, Ueland T (2020)
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
Circ.-Heart Fail., 13 (10), e006643
DOI 10.1161/CIRCHEARTFAILURE.119.006643

Sokolova M, Yang K, Hansen SH, Louwe MC, Kummen M, Hov JER, Sjaastad I, Berge RK, Halvorsen B, Aukrust P, Yndestad A, Ranheim T (2020)
NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet
Sci Rep, 10 (1), 21006
DOI 10.1038/s41598-020-76497-1

Publications 2019

Holt M, Seim BE, Ogaard J, Olsen MB, Woldbaek PR, Kvitting JPE, Aukrust P, Yndestad A, Mollnes TE, Nilsson PH, Louwe MC, Ranheim T (2019)
Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects
Open Heart, 6 (2), UNSP e001098
DOI 10.1136/openhrt-2019-001098

Sokolova M, Ranheim T, Louwe MC, Halvorsen B, Yndestad A, Aukrust P (2019)
NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation-Potential Influence on the Myocardium
J. Cardiovasc. Pharmacol., 74 (4), 276-284
DOI 10.1097/FJC.0000000000000704

Sokolova M, Sjaastad I, Louwe MC, Alfsnes K, Aronsen JM, Zhang LL, Haugstad SB, Bendiksen BA, Lagaard J, Bliksoen M, Lien E, Berge RK, Aukrust P, Ranheim T, Yndestad A (2019)
NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
Front. Immunol., 10, 1621
DOI 10.3389/fimmu.2019.01621

Torp MK, Yang K, Ranheim T, Lauritzen KH, Alfsnes K, Vinge LE, Aukrust P, Stenslokken KO, Yndestad A, Sandanger O (2019)
Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1 beta Expression in Primary Mouse Cardiac Fibroblasts
Front. Immunol., 10, 1285
DOI 10.3389/fimmu.2019.01285

Yang K, Lauritzen KH, Olsen MB, Dahl TB, Ranheim T, Ahmed MS, Attramadal H, Aukrust P, Halvorsen B, Nyman TA, Sandanger O, Yndestad A (2019)
Low Cellular NAD(+) Compromises Lipopolysaccharide-Induced Inflammatory Responses via Inhibiting TLR4 Signal Transduction in Human Monocytes
J. Immunol., 203 (6), 1598-1608
DOI 10.4049/jimmunol.1801382

Ystgaard MB, Scheffler K, Suganthan R, Bjoras M, Ranheim T, Sagen EL, Halvorsen B, Saugstad OD, Yndestad A (2019)
Neuromodulatory Effect of NLRP3 and ASC in Neonatal Hypoxic Ischemic Encephalopathy
Neonatology, 115 (4), 355-362
DOI 10.1159/000497200

Publications 2018

Sokolova M, Sahraoui A, Hoyem M, Ogaard J, Lien E, Aukrust P, Yndestad A, Ranheim T, Scholz H (2018)
NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction
Am. J. Physiol.-Endocrinol. Metab., 315 (5), E912-E923
DOI 10.1152/ajpendo.00461.2017

Publications 2017

Abraityte A, Vinge LE, Askevold ET, Lekva T, Michelsen AE, Ranheim T, Alfsnes K, Fiane A, Aakhus S, Lunde IG, Dahl CP, Aukrust P, Christensen G, Gullestad L, Yndestad A, Ueland T (2017)
Wnt5a is elevated in heart failure and affects cardiac fibroblast function
J. Mol. Med., 95 (7), 767-777
DOI 10.1007/s00109-017-1529-1

Bermudez B, Dahl TB, Medina I, Groeneweg M, Holm S, Montserrat-de la Paz S, Rousch M, Otten J, Herias V, Varela LM, Ranheim T, Yndestad A, Ortega-Gomez A, Abia R, Nagy L, Aukrust P, Muriana FJG, Halvorsen B, Biessen EAL (2017)
Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPAR gamma-Dependent Monocyte Differentiation and Function
Arterioscler. Thromb. Vasc. Biol., 37 (6), 1157-+
DOI 10.1161/ATVBAHA.116.308187

Dhondup Y, Sjaastad I, Sandanger O, Aronsen JM, Ahmed MS, Attramadal H, Finsen AV, Zhang LL, Ranheim T, Alfsnes K, Aukrust P, Christensen G, Yndestad A, Vinge LE (2017)
Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
Mediat. Inflamm., 2017, 9450439
DOI 10.1155/2017/9450439

Sokolova M, Vinge LE, Alfsnes K, Olsen MB, Eide L, Kaasboll OJ, Attramadal H, Torp MK, Fosshaug LE, Rashidi A, Lien E, Finsen AV, Sandanger O, Aukrust P, Ranheim T, Yndestad A (2017)
Palmitate promotes inflammatory responses and cellular senescence in cardiac fibroblasts
Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1862 (2), 234-245
DOI 10.1016/j.bbalip.2016.11.003

Publications 2016

Sandanger O, Gao E, Ranheim T, Bilksoen M, Kaasboll OJ, Alfnes K, Nymo SH, Rashidi A, Ohm IK, Attramadal H, Aukrust P, Vinge LE, Yndestad A (2016)
NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
Biochem. Biophys. Res. Commun., 469 (4), 1012-1020
DOI 10.1016/j.bbrc.2015.12.051

Varghese GP, Folkersen L, Strawbridge RJ, Halvorsen B, Yndestad A, Ranheim T, Krohg-Sorensen K, Skjelland M, Espevik T, Aukrust P, Lengquist M, Hedin U, Jansson JH, Fransen K, Hansson GK, Eriksson P, Sirsjo A (2016)
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
J. Am. Heart Assoc., 5 (5), e003031
DOI 10.1161/JAHA.115.003031

Publications 2015

Cero FT, Hillestad V, Sjaastad I, Yndestad A, Aukrust P, Ranheim T, Lunde IG, Olsen MB, Lien E, Zhang LL, Haugstad SB, Loberg EM, Christensen G, Larsen KO, Skjonsberg OH (2015)
Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice
Am. J. Physiol.-Lung Cell. Mol. Physiol., 309 (4), L378-L387
DOI 10.1152/ajplung.00342.2014

Dhondup Y, Sjaastad I, Scott H, Sandanger O, Zhang LL, Haugstad SB, Aronsen JM, Ranheim T, Holmen SD, Alfsnes K, Ahmed MS, Attramadal H, Gullestad L, Aukrust P, Christensen G, Yndestad A, Vinge LE (2015)
Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
PLoS One, 10 (10), e0139715
DOI 10.1371/journal.pone.0139715

Publications 2014

Astrup E, Ranheim T, Damas JK, Davi G, Santilli F, Jensenius M, Vitale G, Aukrust P, Olano JP, Otterdal K (2014)
Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection
BMC Infect. Dis., 14, 70
DOI 10.1186/1471-2334-14-70

Finsen AV, Ueland T, Sjaastad I, Ranheim T, Ahmed MS, Dahl CP, Askevold ET, Aakhus S, Husberg C, Fiane AE, Lipp M, Gullestad L, Christensen G, Aukrust P, Yndestad A (2014)
The Homeostatic Chemokine CCL21 Predicts Mortality in Aortic Stenosis Patients and Modulates Left Ventricular Remodeling
PLoS One, 9 (11), e112172
DOI 10.1371/journal.pone.0112172

Ohm IK, Alfsnes K, Olsen MB, Ranheim T, Sandanger O, Dahl TB, Aukrust P, Finsen AV, Yndestad A, Vinge LE (2014)
Toll-Like Receptor 9 Mediated Responses in Cardiac Fibroblasts
PLoS One, 9 (8), e104398
DOI 10.1371/journal.pone.0104398

Ohm IK, Gao E, Olsen MB, Alfsnes K, Bliksoen M, Ogaard J, Ranheim T, Nymo SH, Holmen YD, Aukrust P, Yndestad A, Vinge LE (2014)
Toll-Like Receptor 9-Activation during Onset of Myocardial Ischemia Does Not Influence Infarct Extension
PLoS One, 9 (8), e104407
DOI 10.1371/journal.pone.0104407

Publications 2013

Sandanger O, Ranheim T, Vinge LE, Bliksoen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A (2013)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Cardiovasc. Res., 99 (1), 164-174
DOI 10.1093/cvr/cvt091

Sandanger O, Ranheim T, Vinge LE, Bliksoen M, Valen G, Aukrust P, Yndestad A (2013)
A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply
Cardiovasc. Res., 99 (1), 226-227
DOI 10.1093/cvr/cvt130

Publications 2012

Askevold ET, Gullestad L, Aakhus S, Ranheim T, Tonnessen T, Solberg OG, Aukrust P, Ueland T (2012)
Secreted Wnt Modulators in Symptomatic Aortic Stenosis
J. Am. Heart Assoc., 1 (6), e002261
DOI 10.1161/JAHA.112.002261

Bliksoen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GO, Aukrust P, Valen G, Vinge LE (2012)
Increased circulating mitochondrial DNA after myocardial infarction
Int. J. Cardiol., 158 (1), 132-134
DOI 10.1016/j.ijcard.2012.04.047

Dahl TB, Bermudez B, Ranheim T, Otterdal K, Holm S, Biessen EAL, Halvorsen B, Aukrust P (2012)
Unraveling the role of nicotinamide phosphoribosyltransferase on lipids in atherosclerosis
Clin. Lipidol., 7 (6), 697-707
DOI 10.2217/CLP.12.71

Hol J, Otterdal K, Breland UM, Stang E, Pedersen TM, Hagelsteen K, Ranheim T, Kasprzycka M, Halvorsen B, Haraldsen G, Aukrust P (2012)
Statins Affect the Presentation of Endothelial Chemokines by Targeting to Multivesicular Bodies
PLoS One, 7 (7), e40673
DOI 10.1371/journal.pone.0040673

Smedbakken LM, Halvorsen B, Daissormont I, Ranheim T, Michelsen AE, Skjelland M, Sagen EL, Folkersen L, Krohg-Sorensen K, Russell D, Holm S, Ueland T, Fevang B, Hedin U, Yndestad A, Gullestad L, Hansson GK, Biessen EA, Aukrust P (2012)
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization
Atherosclerosis, 224 (1), 266-273
DOI 10.1016/j.atherosclerosis.2012.06.071

Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Oie E, Vinge LE, Sjaastad I, Sandanger O, Ranheim T, Dickstein K, Kjekshus J, Damas JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P (2012)
The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
PLoS One, 7 (3), e33038
DOI 10.1371/journal.pone.0033038

Publications 2011

Dahl T, Ranheim T, Holm S, Berge R, Aukrust P, Halvorsen B (2011)
Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages
Eur. J. Clin. Invest., 41 (10), 1098-1104
DOI 10.1111/j.1365-2362.2011.02515.x

Publications 2010

Cameron J, Ranheim T, Halvorsen B, Kulseth MA, Leren TP, Berge KE (2010)
Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C
Atherosclerosis, 209 (1), 163-166
DOI 10.1016/j.atherosclerosis.2009.08.039

Dahl TB, Haukeland JW, Yndestad A, Ranheim T, Gladhaug IP, Damas JK, Haaland T, Loberg EM, Arntsen B, Birkeland K, Bjoro K, Ulven SM, Konopski Z, Nebb HI, Aukrust P, Halvorsen B (2010)
Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease
J. Clin. Endocrinol. Metab., 95 (6), 3039-3047
DOI 10.1210/jc.2009-2148

Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sorensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010)
Increased YKL-40 expression in patients with carotid atherosclerosis
Atherosclerosis, 211 (2), 589-595
DOI 10.1016/j.atherosclerosis.2010.02.035

Publications 2009

Holla OL, Kulseth MA, Berge KE, Leren TP, Ranheim T (2009)
Nonsense-mediated decay of human LDL receptor mRNA
Scand. J. Clin. Lab. Invest., 69 (3), PII 910664994-417
DOI 10.1080/00365510802707163

Holla OL, Nakken S, Mattingsdal M, Ranheim T, Berge KE, Defesche JC, Leren TP (2009)
Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses
Mol. Genet. Metab., 96 (4), 245-252
DOI 10.1016/j.ymgme.2008.12.014

Tveten K, Ranheim T, Berge KE, Leren TP, Kulseth MA (2009)
The effect of bafilomycin A1 and protease inhibitors on the degradation and recycling of a Class 5-mutant LDLR
Acta Biochim. Biophys. Sin., 41 (3), 246-255
DOI 10.1093/abbs/gmp008

Publications 2008

Cameron J, Holla OL, Berge KE, Kulseth MA, Ranheim T, Leren TP, Laerdahl JK (2008)
Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion
FEBS J., 275 (16), 4121-4133
DOI 10.1111/j.1742-4658.2008.06553.x

Cameron J, Holla OL, Laerdahl JK, Kulseth MA, Ranheim T, Rognes T, Berge KE, Leren TP (2008)
Characterization of novel mutations in the catalytic domain of the PCSK9 gene
J. Intern. Med., 263 (4), 420-431
DOI 10.1111/j.1365-2796.2007.01915.x

Cameron J, Ranheim T, Kulseth MA, Leren TP, Berge KE (2008)
Berberine decreases PCSK9 expression in HepG2 cells
Atherosclerosis, 201 (2), 266-273
DOI 10.1016/j.atherosclerosis.2008.02.004

Ranheim T, Mattingsdal M, Lindvall JM, Holla OL, Berge KE, Kulseth MA, Leren TP (2008)
Genome-wide expression analysis of cells expressing gain of function mutant D374Y-PCSK9
J. Cell. Physiol., 217 (2), 459-467
DOI 10.1002/jcp.21519

Publications 2007

Holla OL, Cameron J, Berge KE, Ranheim T, Leren TP (2007)
Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly
BMC Cell Biol., 8, 9
DOI 10.1186/1471-2121-8-9

Tveten K, Holla OL, Ranheim T, Berge KE, Leren TP, Kulseth MA (2007)
4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor
FEBS J., 274 (8), 1881-1893
DOI 10.1111/j.1742-4658.2007.05735.x

Publications 2006

Cameron J, Holla OL, Ranheim T, Kulseth MA, Berge KE, Leren TP (2006)
Effect of mutations in the PCSK9 gene on the cell surface LDL receptors
Hum. Mol. Genet., 15 (9), 1551-1558
DOI 10.1093/hmg/ddl077

Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA (2006)
Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression
Am. J. Physiol.-Endocrinol. Metab., 290 (2), E326-E333
DOI 10.1152/ajpendo.00020.2005

Holla OL, Cameron J, Berge KE, Kulseth MA, Ranheim T, Leren TP (2006)
Low-density lipoprotein receptor activity in Epstein-Barr virus-transformed lymphocytes from heterozygotes for the D374Y mutation in the PCSK9 gene
Scand. J. Clin. Lab. Invest., 66 (4), 317-328
DOI 10.1080/00365510600672775

Ranheim T, Kulseth MA, Berge KE, Leren TP (2006)
Model system for phenotypic characterization of sequence variations in the LDL receptor gene
Clin. Chem., 52 (8), 1469-1479
DOI 10.1373/clinchem.2006.068627

Sorensen S, Ranheim T, Bakken KS, Leren TP, Kulseth MA (2006)
Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress
J. Biol. Chem., 281 (1), 468-476
DOI 10.1074/jbc.M507071200

Tveten K, Ranheim T, Berge KE, Leren TP, Kulseth MA (2006)
Analysis of alternatively spliced isoforms of human LDL receptor mRNA
Clin. Chim. Acta, 373 (1-2), 151-157
DOI 10.1016/j.cca.2006.05.031

Publications 2005

Ranheim T, Halvorsen B (2005)
Coffee consumption and human health - beneficial or detrimental? - Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus
Mol. Nutr. Food Res., 49 (3), 274-284
DOI 10.1002/mnfr.200400109

Publications 2004

Enger A, Strand OA, Ranheim T, Hellum KB (2004)
Exflagellation of microgametocytes in Plasmodium vivax malaria: A diagnostic conundrum
Med. Princ. Pract., 13 (5), 298-300
DOI 10.1159/000079533

Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA (2004)
Adiponectin is reduced in gestational diabetes mellitus in normal weight women
Acta Obstet. Gynecol. Scand., 83 (4), 341-347
DOI 10.1111/j.0001-6349.2004.00413.x

Publications 2003

Grove S, Johansen R, Dannevig BH, Reitan LJ, Ranheim T (2003)
Experimental infection of Atlantic halibut Hippoglossus hippoglossus with nodavirus: tissue distribution and immune response
Dis. Aquat. Org., 53 (3), 211-221
DOI 10.3354/dao053211

Staff AC, Ranheim T, Halvorsen B (2003)
Augmented PLA(2) activity in pre-eclamptic decidual tissue - A key player in the pathophysiology of 'acute atherosis' in pre-eclampsia?
Placenta, 24 (10), 965-973
DOI 10.1016/S0143-4004(03)00175-9

Publications 2002

Gedde-Dahl A, Kulseth MA, Ranheim T, Drevon CA, Rustan AC (2002)
Reduced secretion of triacylglycerol in CaCo-2 cells transfected with intestinal fatty acid-binding protein
Lipids, 37 (1), 61-68
DOI 10.1007/s11745-002-0864-8

Johansen R, Ranheim T, Hansen MK, Taksdal T, Totland GK (2002)
Pathological changes in juvenile Atlantic halibut Hippoglossus hippoglossus persistently infected with nodavirus
Dis. Aquat. Org., 50 (3), 161-169

Publications 2001

Halvorsen B, Staff AC, Henriksen T, Sawamura T, Ranheim T (2001)
8-iso-prostaglandin F-2 alpha increases expression of LOX-1 in JAR cells
Hypertension, 37 (4), 1184-1190
DOI 10.1161/01.HYP.37.4.1184

Ranheim T, Staff AC, Henriksen T (2001)
VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery
Acta Obstet. Gynecol. Scand., 80 (2), 93-98
DOI 10.1034/j.1600-0412.2001.080002093.x

Publications 2000

Staff AC, Ranheim T, Henriksen T, Halvorsen B (2000)
8-Iso-prostaglandin F-2 alpha reduces trophoblast invasion and matrix metalloproteinase activity
Hypertension, 35 (6), 1307-1313
DOI 10.1161/01.HYP.35.6.1307

Publications 1999

Berge K, Tronstad KJ, Abdi-Dezfuli F, Ranheim T, Mahesparan R, Bjerkvig R, Berge RK (1999)
Poorly oxidizable fatty acid analogues inhibit the proliferation of cancer cells in culture
Adv.Exp.Med.Biol., 466, 205-210

Kulseth MA, Kolset SO, Ranheim T (1999)
Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-alpha and IL-1 alpha
Biochim. Biophys. Acta-Gen. Subj., 1428 (2-3), 225-232
DOI 10.1016/S0304-4165(99)00096-3

Staff AC, Halvorsen B, Ranheim T, Henriksen T (1999)
Elevated level of free 8-iso-prostaglandin F-2 alpha in the decidua basalis of women with preeclampsia
Am. J. Obstet. Gynecol., 181 (5), 1211-1215
DOI 10.1016/S0002-9378(99)70110-9

Staff AC, Ranheim T, Khoury J, Henriksen T (1999)
Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia
Am. J. Obstet. Gynecol., 180 (3), 587-592
DOI 10.1016/S0002-9378(99)70259-0

Publications 1998

Halvorsen B, Ranheim T, Nenseter MS, Huggett AC, Drevon CA (1998)
Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts
J. Lipid Res., 39 (4), 901-912

Publications 1997

Rustan AC, Halvorsen B, Huggett AC, Ranheim T, Drevon CA (1997)
Effect of coffee lipids (cafestol and kahweol) on regulation of cholesterol metabolism in HepG2 cells
Arterioscler. Thromb. Vasc. Biol., 17 (10), 2140-2149
DOI 10.1161/01.ATV.17.10.2140

Rustan AC, Halvorsen B, Ranheim T, Drevon CA (1997)
Cafestol (a coffee lipid) decreases uptake of low-density lipoprotein (LDL) in human skin fibroblasts and liver cells
Ann.NY Acad.Sci., 827, 158-162
DOI 10.1111/j.1749-6632.1997.tb51830.x

Publications 1995

GEDDEDAHL A, RANHEIM T, DREVON CA, SKREDE S, BERGE RK, RUSTAN AC (1995)
TETRADECYLTHIOACETIC ACID (A 3-THIA FATTY-ACID) DECREASES TRIACYLGLYCEROL SECRETION IN CACO-2 CELLS
J. Lipid Res., 36 (3), 535-543

RANHEIM T, HALVORSEN B, HUGGETT AC, BLOMHOFF R, DREVON CA (1995)
EFFECT OF A COFFEE LIPID (CAFESTOL) ON REGULATION OF LIPID-METABOLISM IN CACO-2 CELLS
J. Lipid Res., 36 (10), 2079-2089

Publications 1994

Ranheim T (1994)
Lipid metabolism in cultured intestinal cells: effect of eicosapentaenoic acid (20:5, n-3), tetradecylthioacetic acid and a coffee lipid (cafestol) on the lipid metabolism in CaCo-2 cells
Institute for Nutrition Research, University of Oslo, [Oslo], 1 b. (flere pag.)
BIBSYS 95032423x, ISBN 82-91061-58-0

RANHEIM T, GEDDEDAHL A, RUSTAN AC, DREVON CA (1994)
FATTY-ACID UPTAKE AND METABOLISM IN CACO-2 CELLS - EICOSAPENTAENOIC ACID (20/5(N-3)) AND OLEIC ACID(18/1(N-9)) PRESENTED IN ASSOCIATION WITH MICELLES OR ALBUMIN
Biochim. Biophys. Acta-Lipids Lipid Metab., 1212 (3), 295-304
DOI 10.1016/0005-2760(94)90203-8

RANHEIM T, GEDDEDAHL A, RUSTAN AC, DREVON CA (1994)
EFFECT OF CHRONIC INCUBATION OF CACO-2 CELLS WITH EICOSAPENTAENOIC ACID (20/5, N-3) AND OLEIC-ACID (18/1, N-9) ON TRIACYLGLYCEROL PRODUCTION
Biochem. J., 303, 155-161
DOI 10.1042/bj3030155

Publications 1992

RANHEIM T, GEDDEDAHL A, RUSTAN AC, DREVON CA (1992)
INFLUENCE OF EICOSAPENTAENOIC ACID (20-5, N-3) ON SECRETION OF LIPOPROTEINS IN CACO-2 CELLS
J. Lipid Res., 33 (9), 1281-1293

Publications 1990

Ranheim T (1990)
Characteristics of a human intestinal adenocarcinoma cellline (CACO-2) in relation to metabolism of eicosapentaenoic acid (20:5, n-3) and oleic acid (18:1, n-9)
Institute for Nutrition Research, University of Oslo ; Bekkestua : Stabekk høgskole, Oslo, 43 s.
BIBSYS 971595380

Publications 1988

DAVIES CD, RANHEIM T, MALIK Z, ROFSTAD EK, MOAN J, LINDMO T (1988)
RELATIONSHIP BETWEEN CHANGES IN ANTIGEN EXPRESSION AND PROTEIN-SYNTHESIS IN HUMAN-MELANOMA CELLS AFTER HYPERTHERMIA AND PHOTODYNAMIC TREATMENT
Br. J. Cancer, 58 (3), 306-313
DOI 10.1038/bjc.1988.209